TD Asset Management Inc trimmed its stake in shares of OR Royalties Inc. (NYSE:OR – Free Report) by 19.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 889,926 shares of the basic materials company’s stock after selling 213,375 shares during the quarter. TD Asset Management Inc owned approximately 0.48% of OR Royalties worth $31,551,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds also recently made changes to their positions in the stock. Cibc World Market Inc. raised its position in shares of OR Royalties by 19.3% during the fourth quarter. Cibc World Market Inc. now owns 360,911 shares of the basic materials company’s stock worth $12,787,000 after acquiring an additional 58,369 shares during the last quarter. Norges Bank bought a new position in shares of OR Royalties during the fourth quarter worth about $88,597,000. Geode Capital Management LLC raised its position in shares of OR Royalties by 16.3% during the fourth quarter. Geode Capital Management LLC now owns 130,575 shares of the basic materials company’s stock worth $4,723,000 after acquiring an additional 18,308 shares during the last quarter. HighTower Advisors LLC raised its position in shares of OR Royalties by 6.4% during the fourth quarter. HighTower Advisors LLC now owns 84,597 shares of the basic materials company’s stock worth $2,994,000 after acquiring an additional 5,079 shares during the last quarter. Finally, Dana Investment Advisors Inc. bought a new position in shares of OR Royalties during the fourth quarter worth about $847,000. 68.52% of the stock is currently owned by institutional investors.
OR Royalties Price Performance
NYSE OR opened at $33.81 on Friday. The business has a 50 day simple moving average of $38.03 and a 200 day simple moving average of $38.69. OR Royalties Inc. has a one year low of $24.76 and a one year high of $48.06. The stock has a market capitalization of $6.34 billion, a P/E ratio of 25.23 and a beta of 0.70.
OR Royalties Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Tuesday, June 30th will be paid a $0.065 dividend. This represents a $0.26 dividend on an annualized basis and a yield of 0.8%. This is a boost from OR Royalties’s previous quarterly dividend of $0.06. The ex-dividend date of this dividend is Tuesday, June 30th. OR Royalties’s payout ratio is 16.42%.
Analyst Ratings Changes
A number of equities analysts have recently issued reports on the company. Zacks Research downgraded OR Royalties from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, March 31st. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $56.00 target price on shares of OR Royalties in a research note on Friday, April 10th. TD Securities reaffirmed a “hold” rating on shares of OR Royalties in a research note on Monday, February 23rd. Wall Street Zen cut OR Royalties from a “buy” rating to a “hold” rating in a research note on Saturday. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of OR Royalties in a research note on Friday, May 22nd. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $46.50.
View Our Latest Analysis on OR Royalties
OR Royalties Profile
OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.
The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.
See Also
- Five stocks we like better than OR Royalties
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Receive News & Ratings for OR Royalties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OR Royalties and related companies with MarketBeat.com's FREE daily email newsletter.
